Perfusion by blood provides tissues with vital oxygen and nutrients, while removing waste products and distributing signaling molecules around the organism. The measurement of microvascular blood perfusion provides researchers with critical information in a number of research applications where blood supply has been disrupted.
Oxford Optronix blood flow monitors will be of interest therefore to life scientists wishing to directly and continuously measure local microvascular blood perfusion in in vivo models of ischemia-related disorders.
OxyFlo™ devices are laser Doppler flowmetry (LDF) monitors intended for monitoring of relative microvascular blood flow in living tissues.
Most applications are concerned with monitoring the competence of regional (microvascular) blood supply in specialties such as peripheral vascular disorders, cerebral perfusion monitoring in models of stroke and brain injury, tumour perfusion monitoring / angiogenesis, blood flow in free flaps and pedicle flaps, wound healing, surgery, transplantation and more.
Oxford Optronix Ltd. was founded when its current CEO pioneered the transition of the then nascent laser-Doppler flowmetry technology into a commercially viable product in the early 1990’s. Oxford Optronix remains a pioneer in the development of LDF technology and continues to set unrivaled standards of reliability, robustness and sensitivity, with the OxyFlo™ brand now well-established the world over in biomedical ischaemia research.
With the launch of OxyFlo™ Pro in 2013, a third-generation LDF platform, Oxford Optronix blends contemporary design, plug and play convenience and touch-screen operation to provide one of the most advanced and reliable blood flow monitors on the market.
Intended use statement:
OxyFlo™ and OxyFlo™ Pro are intended for laboratory, industrial and research use only.
OxyFlo™ and OxyFlo™ Pro are NOT intended for use in human subjects/patients.